TEM
Tempus AI Announces $192.5M Data Licensing Agreements with Bristol-Myers Squibb and Pathos AI
Tempus AI has entered into a series of agreements with Bristol-Myers Squibb (BMS) and Pathos AI to expand the use of its de-identified multimodal real-world...
